Image Credit: STAT News

STAT+: Bristol Myers to partner with BioNTech on experimental cancer drug

Watchdoq June 2, 2025

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.